Intended Use: Foundation for Risk-Based Validation

A Critical Step in Transitioning to CSA

Executive Summary

Risk-based validation is a cornerstone of the FDA’s recent CSA Final Guidance. It depends on an accurate Intended Business Use statement—or more simply, intended use. Before you can identify Critical Data Elements (CDE), create an objective risk assessment, or determine validation testing scope, a clear intended use statement is essenti…